Author:
Mai Zhipeng,Zhu Ming,Feng Tianrui,Zhou Zhien,Zhou Yi,Wang Dong,Yuan Runqiang,Xiao Yu,Wang Jiarou,Sun Hao,Yan Weigang
Funder
the National High Level Hospital Clinical Research Funding
the third batch of social public welfare and basic research projects in Zhongshan City in 2021
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Sweat SD, Pacelli A, Murphy GP, Bostwick DG (1998) Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. Urology 52:637–640
2. Meissner VH, Rauscher I, Schwamborn K, Neumann J, Miller G, Weber W et al (2022) Radical prostatectomy without prior biopsy following multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography. Eur Urol 82:156–160
3. Gultekin MH, Demirci E, Turegun FA, Kabasakal L, Sahin OE, Ocak M et al (2020) The role of 68GA-PSMA PET/CT scan in patients with prostate adenocarcinoma who underwent radical prostatectomy. Urol J 18:58–65
4. Murthy V, Sonni I, Jariwala N, Juarez R, Reiter RE, Raman SS et al (2021) The role of PSMA PETCT and PETMRI in the initial staging of prostate cancer. Eur Urol Focus 7:258–266
5. Wang R, Shen G, Yang R, Ma X, Tian R (2020) 68Ga-PSMA PET/MRI for the diagnosis of primary and biochemically recurrent prostate cancer: a meta-analysis. Eur J Radiol 130:109131